MARKET

NRXS

NRXS

Neuraxis Inc
AMEX
2.670
-0.040
-1.48%
After Hours: 2.670 0 0.00% 16:10 12/05 EST
OPEN
2.740
PREV CLOSE
2.710
HIGH
2.750
LOW
2.610
VOLUME
22.96K
TURNOVER
--
52 WEEK HIGH
6.20
52 WEEK LOW
1.330
MARKET CAP
28.44M
P/E (TTM)
-2.6184
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Personalis (PSNL), Dyadic International (DYAI) and NeurAxis, Inc. (NRXS)
TipRanks · 4d ago
Neuraxis secures VA Federal Supply Schedule contract
TipRanks · 4d ago
Weekly Report: what happened at NRXS last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at NRXS last week (1117-1121)?
Weekly Report · 11/24 10:16
NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth
NASDAQ · 11/17 17:17
Weekly Report: what happened at NRXS last week (1110-1114)?
Weekly Report · 11/17 10:16
Neuraxis announces new medical policy coverage in Michigan
TipRanks · 11/12 13:31
NeurAxis, Inc. Reports Increased Sales Amidst Ongoing Losses
TipRanks · 11/12 04:11
More
About NRXS
Neuraxis, Inc. is a medical technology company. The Company is focused on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults. It focuses on advancing science and leveraging evidence-based medicine to drive the adoption of its IB-Stim therapy, which is its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim is a food and drug administration (FDA) cleared for functional abdominal pain associated with irritable bowel syndrome (IBS) in adolescents 11-18 years old. The Company’s second product, the Rectal Expulsion Device (RED), is indicated to evaluate the neuromuscular function of a patient’s ability to expel its contents from the rectum and as a qualitative test for rectal hypersensitivity. RED (K242304, 2024) helps identify patients with rectal hypersensitivity who experience a desire or urge defecating at lower volumes of distension.

Webull offers Neuraxis Inc stock information, including AMEX: NRXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXS stock methods without spending real money on the virtual paper trading platform.